Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPERA-DISCONTINUATION antidepressant discontinuation study
2019-001518-40Phase 4Terminated
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sertraline and citalopram in major depressive disorder (MDD) (2 cohorts), sponsored by Amsterdam University Medical Center. Primary endpoints: Sustained remission time and Suicide attempt. Started Jul 2019; status: terminated.
02
Drugs
sertralinecitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2019-001518-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001518-40.